tiprankstipranks
Trending News
More News >
Idexx Laboratories (IDXX)
NASDAQ:IDXX
US Market

Idexx Laboratories (IDXX) Financial Statements

Compare
2,141 Followers

Idexx Laboratories Financial Overview

Idexx Laboratories's market cap is currently $54.78B. The company's EPS TTM is $3.4; its P/E ratio is 54.78; Idexx Laboratories is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $2.93. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 3.90B$ 3.66B$ 3.37B$ 3.22B$ 2.71B
Gross Profit$ 2.38B$ 2.19B$ 2.00B$ 1.89B$ 1.57B
Operating Income$ 1.13B$ 1.10B$ 898.76M$ 932.03M$ 694.52M
EBITDA$ 1.28B$ 1.22B$ 1.01B$ 1.04B$ 793.81M
Net Income$ 887.87M$ 845.04M$ 679.09M$ 744.85M$ 581.78M
Balance Sheet
Cash & Short-Term Investments$ 288.27M$ 453.93M$ 112.55M$ 144.45M$ 383.93M
Total Assets$ 3.29B$ 3.26B$ 2.75B$ 2.44B$ 2.29B
Total Debt$ 986.95M$ 1.07B$ 1.47B$ 1.03B$ 1.00B
Net Debt$ 698.68M$ 613.42M$ 1.36B$ 886.55M$ 619.32M
Total Liabilities$ 1.70B$ 1.78B$ 2.14B$ 1.75B$ 1.66B
Stockholders' Equity$ 1.60B$ 1.48B$ 608.74M$ 689.99M$ 632.09M
Cash Flow
Free Cash Flow$ 798.08M$ 772.88M$ 394.15M$ 636.00M$ 540.44M
Operating Cash Flow$ 929.00M$ 906.51M$ 542.98M$ 755.55M$ 648.06M
Investing Cash Flow$ -207.06M$ -125.25M$ -195.35M$ -292.97M$ -109.38M
Financing Cash Flow$ -878.07M$ -442.00M$ -370.94M$ -697.41M$ -248.42M
Currency in USD

Idexx Laboratories Earnings and Revenue History

Idexx Laboratories Debt to Assets

Idexx Laboratories Cash Flow

Idexx Laboratories Forecast EPS vs Actual EPS